Practical approach to screening for scleroderma-associated pulmonary arterial hypertension (Q37955130)

25 August 2017

title

Practical approach to screening for scleroderma-associated pulmonary arterial hypertension (English)

1 reference

25 August 2017

main subject

arterial hypertension

0 references

author name string

Aryeh Fischer

series ordinal

1

1 reference

25 August 2017

Todd M Bull

series ordinal

2

1 reference

25 August 2017

Virginia D Steen

series ordinal

3

1 reference

25 August 2017

publication date

1 March 2012

1 reference

Arthritis Care and Research

25 August 2017

published in

1 reference

25 August 2017

volume

64

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

303-310

1 reference

Changes in causes of death in systemic sclerosis, 1972-2002

25 August 2017

cites work

1 reference

Connective tissue associated pulmonary arterial hypertension

21 January 2018

1 reference

Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease

21 January 2018

1 reference

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

21 January 2018

1 reference

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

21 January 2018

1 reference

Screening for pulmonary arterial hypertension in systemic sclerosis

21 January 2018

1 reference

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.

21 January 2018

1 reference

Prostanoid therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

21 January 2018

1 reference

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

21 January 2018

1 reference

Screening and therapy of pulmonary hypertension in systemic sclerosis

21 January 2018

1 reference

Tadalafil therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

Pulmonary arterial hypertension associated to connective tissue diseases.

21 January 2018

1 reference

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

21 January 2018

1 reference

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

21 January 2018

1 reference

A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism

21 January 2018

1 reference

Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

21 January 2018

1 reference

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study

21 January 2018

1 reference

Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome

21 January 2018

1 reference

Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

21 January 2018

1 reference

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).

21 January 2018

1 reference

Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed.

21 January 2018

1 reference

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

Diagnosis and management of pulmonary hypertension in systemic sclerosis

21 January 2018

1 reference

Antiphospholipid antibody syndrome and autoimmune diseases

21 January 2018

1 reference

Pulmonary veno-occlusive disease: a case series and new observations

21 January 2018

1 reference

Autoantibodies in systemic sclerosis

21 January 2018

1 reference

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

21 January 2018

1 reference

Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease

21 January 2018

1 reference

Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic Sclerosis

21 January 2018

1 reference

Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis

21 January 2018

1 reference

Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis.

21 January 2018

1 reference

Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease

21 January 2018

1 reference

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

21 January 2018

1 reference

N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers

21 January 2018

1 reference

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension

21 January 2018

1 reference

Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis

21 January 2018

1 reference

Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.

21 January 2018

1 reference

Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings

21 January 2018

1 reference

Increased Expression of Growth Differentiation Factor-15 in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

21 January 2018

1 reference

Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers

21 January 2018

1 reference

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.20693

1 reference

25 August 2017

1 reference